NCT02586844View on ClinicalTrials.gov

Prospective Comprehensive Molecular Profiling In Neuroendocrine Tumors

CompletedOBSERVATIONAL
Enrollment

13

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
Neuroendocrine TumorsPancreatic Neuroendocrine Tumors
Trial Locations (1)

M5G2M9

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
collaborator

Princess Margaret Hospital, Canada

OTHER

lead

University Health Network, Toronto

OTHER

NCT02586844 - Prospective Comprehensive Molecular Profiling In Neuroendocrine Tumors | Biotech Hunter | Biotech Hunter